| dc.contributor.advisor | 郭維裕 | zh_TW |
| dc.contributor.advisor | Kuo, Wei-Yu | en_US |
| dc.contributor.author (Authors) | 劉彥谷 | zh_TW |
| dc.contributor.author (Authors) | Liu, Yen-Ku | en_US |
| dc.creator (作者) | 劉彥谷 | zh_TW |
| dc.creator (作者) | Liu, Yen-Ku | en_US |
| dc.date (日期) | 2024 | en_US |
| dc.date.accessioned | 5-Aug-2024 12:34:12 (UTC+8) | - |
| dc.date.available | 5-Aug-2024 12:34:12 (UTC+8) | - |
| dc.date.issued (上傳時間) | 5-Aug-2024 12:34:12 (UTC+8) | - |
| dc.identifier (Other Identifiers) | G0107932165 | en_US |
| dc.identifier.uri (URI) | https://nccur.lib.nccu.edu.tw/handle/140.119/152510 | - |
| dc.description (描述) | 碩士 | zh_TW |
| dc.description (描述) | 國立政治大學 | zh_TW |
| dc.description (描述) | 經營管理碩士學程(EMBA) | zh_TW |
| dc.description (描述) | 107932165 | zh_TW |
| dc.description.abstract (摘要) | 醫療產業，曾是一個非常封閉且保守的產業，但因為新冠疫情（COVID-19）的肆虐，全球政府、企業及新創無不絞盡腦汁來協助醫療產業的改善。為了盡快解決疫情問題，這段期間的醫療科技以顯而易見的速度快速改良及進步。加上政府部門積極的開放醫療管制的法規，許多新的技術，包括信使核糖核酸（mRNA）技術、醫療院所視訊醫療服務、醫療物聯網（The Internet of Medical Things，IoMT）等，皆雨後春筍般的冒出。
另一方面，國際局勢的詭譎多變，曾經引以為傲的全球供應鏈，卻因為大國間的角力，中美貿易戰等問題，讓全球生產供應鏈重新聚焦東南亞市場。隨著眾多外商進入東南亞國家，當地的醫療系統卻無法及時跟上，此時亟待先進國家的醫療技術、醫療人才、資金及醫療資源等投入，同時，為了引入高端技術及產品到東南亞，東南亞各國也提供不同的優惠方案來吸引外商。然而，東南亞醫療市場既有的問題並非一朝一夕可以解決，包括醫療人力的不足、醫療技術的落後、各國保險制度的差異等，都是醫療業者要進入該國市場所需深思的地方。
本文將以醫療產業進入東南亞的人口大國—印尼為例，評估並分析其政府政策、經濟狀況、醫療產業現況、醫療人力資源等關鍵因素對產業的影響。並以S公司，一間於臺灣及中國大陸專注於醫療管理顧問及經銷代理公司的核心能耐為基礎，評估其在印尼市場的機會與風險。 | zh_TW |
| dc.description.abstract (摘要) | The medical industry used to be a very closed and conservative industry. However, due to the rampage of the COVID-19 pandemic, governments, corporations, and startups worldwide are brainstorming to assist in improving the medical industry. In order to quickly address the pandemic, medical technology during this period has rapidly improved and advanced at a visible speed. With government departments actively loosening medical regulatory laws, many new technologies, including messenger RNA (mRNA) technology, telemedicine services in medical institutions, and the Internet of Medical Things (IoMT), have emerged rapidly.
On the other hand, the international situation is unpredictable and ever-changing. The once proud global supply chain has refocused on the Southeast Asian market due to struggles between major powers, such as the US-China trade war. With numerous foreign companies entering Southeast Asian countries, the local medical systems are struggling to keep up. It is imperative for advanced nations to invest in Southeast Asia's medical technology, healthcare professionals, international funding, and medical resources to bridge the gap. Additionally, Southeast Asian countries are offering various incentives to attract foreign investments for introducing high-end technology and products. However, existing issues in the Southeast Asian medical market, such as inadequate medical personnel, outdated medical technology, and differences in insurance systems, cannot be resolved in a short time. These are critical considerations for healthcare industry players seeking entry into these markets.
This article will use Indonesia, a populous country in Southeast Asia, as a case study for the medical industry entering the region. It will evaluate and analyze the impact of key factors such as government policies, economic conditions, the current state of the medical industry, and healthcare manpower. Based on the core capabilities of Company S, a company specializing in medical management consulting and distribution agency in Taiwan and mainland China, the opportunities and risks in the Indonesian market will be assessed. | en_US |
| dc.description.tableofcontents | 第一章 緒論 8
第一節 研究背景與動機 8
第二節 研究目的 9
第三節 研究流程 9
第二章 文獻探討及理論分析 11
第一節 外部分析工具：總體環境分析 11
第二節 內部分析工具：強弱危機分析、五力分析、價值鏈分析 15
第三章 醫療產業環境分析 21
第一節 總體經濟環境分析 21
第二節 東南亞經濟環境分析 22
第三節 醫療產業環境分析 23
第四節 印尼醫療環境分析 25
第五節 IoMT市場分析 30
（一）IoMT產業介紹 31
（二）IoMT應用的領域及商業模式 33
（三）IoMT遭遇的問題 35
（四）IoMT的發展機遇 36
第四章 個案分析：以S醫療公司為例 40
第一節 S醫療公司簡介 40
第二節 S醫療公司經營策略 41
第三節 S醫療體系優勢分析 45
第四節 競爭者分析 56
第五節 IoMT相關廠商分析 60
第六節 IoMT於醫療領域上的機會 62
第五章 S公司的營運策略 64
第一節 印尼經營策略 64
第二節 風險及替代方案 70
第三節 關鍵檢查點及出場策略 71
第六章 結論及建議 74
第一節 結論 74
第二節 建議 76
參考文獻 78 | zh_TW |
| dc.format.extent | 1635005 bytes | - |
| dc.format.mimetype | application/pdf | - |
| dc.source.uri (資料來源) | http://thesis.lib.nccu.edu.tw/record/#G0107932165 | en_US |
| dc.subject (關鍵詞) | 醫療物聯網 | zh_TW |
| dc.subject (關鍵詞) | 醫療市場 | zh_TW |
| dc.subject (關鍵詞) | 印尼 | zh_TW |
| dc.subject (關鍵詞) | Medical internet of things | en_US |
| dc.subject (關鍵詞) | medical market | en_US |
| dc.subject (關鍵詞) | Indonesia | en_US |
| dc.title (題名) | 醫療業在東南亞的經營策略探討 - 以S醫療公司在印尼市場為例 | zh_TW |
| dc.title (題名) | The Business Strategy of The Medical Industry in Southeast Asia: A Case Study of S Company | en_US |
| dc.type (資料類型) | thesis | en_US |
| dc.relation.reference (參考文獻) | [1] 台灣醫療爭議案件數統計. (2017, January 19). 財團法人台灣醫療改革基金會. 檢自https://www.thrf.org.tw/medicaldisputes/1642 (檢索日期 May 11, 2024)
[2] 陳端武 (Ed.). (2017, January 25). IoT結合穿戴式醫療裝置 資料分析技術可即時監測患者病況. DIGITIMES. 檢自https://www.digitimes.com.tw/tech/dt/n/shwnws.asp?id=0000492168_mgl24zib5noyn19nr4x3a (檢索日期 May 11, 2024)
[3] 台灣野村總研諮詢顧問股份有限公司 (Ed.). (2018). 衛生福利部 107 年度 「國際醫療健康產業新南向佈局計畫」附冊、新南向國家醫事人員訓練與國際醫療市場 商情資料庫（印尼）. 檢自https://wwwfs.vghks.gov.tw/Download.ashx?u=LzAwMS9WZ2hrc1VwbG9hZEZpbGVzLzM3OC9yZWxmaWxlLzAvMC9hMzUzODA2MS1iYzNlLTRjYzYtYjRkOS1hNTMyYjFiNzM0NGQucGRm&n=5Y2w5bC86Yar6KGb5ZWG5oOF6LOH5paZ5bqrLnBkZg%3D%3D&icon=.pdf (檢索日期 May 11, 2024)
[4] Khoshafian, S. (2018, January 19). Digital Transformation of Healthcare: IoMT Connectivity, AI, and Value Streams. The Iot Magazine. 檢自
https://theiotmagazine.com/digital-transformation-of-healthcare-iomt-connectivity-ai-and-value-streams-62edc0f2be1a (檢索日期 May 11, 2024)
[5] Martin, R. (2018, November 30). Internet of Medical Things (IoMT) – The Future of Healthcare. Ignite. 檢自
https://igniteoutsourcing.com/healthcare/internet-of-medical-things-iomt-examples/ (檢索日期 May 11, 2024)
[6] 原水文化. (2018, December 22). 醫院間資料有互通嗎？如果要換醫院時，我該怎麼做－《蒼藍鴿醫師告訴你》. 愛．長照. 檢自
https://www.ilong-termcare.com/Article/Detail/2936 (檢索日期 May 11, 2024)
[7] 2019 醫療照護產業展望. (2019, February 14). Deloitte. 檢自https://www2.deloitte.com/tw/tc/pages/life-sciences-and-healthcare/articles/2019-healthcare-report.html (檢索日期 May 11, 2024)
[8] 蔡騰輝 (Ed.). (2019, July 25). 預防醫學從IoMT做起 衛福部與北市府著手佈建醫療物聯網. DIGITIMES. 檢自https://www.digitimes.com.tw/tech/dt/n/shwnws.asp?id=0000564654_4MA5NM296Y3JFX3336MDG&packageid=13532 (檢索日期 May 11, 2024)
[9] Top 10 Players of the Internet of Medical Things (IoMT) Changing the Industry’s Face. (2022, May 30). Fortune Business Insights. 檢自https://www.fortunebusinessinsights.com/blog/top-players-in-the-internet-of-medical-things-iomt-sector-10684 (檢索日期 May 11, 2024)
[10] 印尼醫衛產業概況與需求. (2022, September 22). 醫衛新南向產業e鏈結. 檢自https://nsp.mohw.org.tw/doc/91 (檢索日期 May 11, 2024)
[11] 醫事爭議處理、鑑定等相關業務. (2023, July 7). 衛生福利部醫事司. 檢自https://dep.mohw.gov.tw/DOMA/cp-2712-7681-106.html (檢索日期 May 11, 2024)
[12] 巫佩蒂. (2024, January 23). 2024年東協加三的經濟仍呈持續成長趨勢. 中華經濟研究院. 檢自
https://web.wtocenter.org.tw/Page/120/393779 (檢索日期 May 11, 2024)
[13] 常見的醫療糾紛及法律責任. (2024, March 29). 臺灣臺北地方檢察署. 檢自https://www.tpc.moj.gov.tw/292885/976681/292904/322555/ (檢索日期 May 11, 2024)
[14] Internet of Medical Things Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029). (2023). Mordor Intelligence. 檢自
https://www.mordorintelligence.com/industry-reports/internet-of-medical-things-market (檢索日期 May 11, 2024)
[15] SWOT分析表怎麼做？4個面向與定義，為企業和個人指出成功模式！. (2024, April 12). 經理人. 檢自
https://www.managertoday.com.tw/glossary/view/15 (檢索日期 May 11, 2024)
[16] 景氣指標簡介. (2024, May 10). 國家發展委員會. 檢自https://www.ndc.gov.tw/nc_335_2235 (檢索日期 May 11, 2024)
[17] 【2024投資展望】重新審視總體經濟情勢. (2024, May 11). 瀚亞投資. 檢自 https://www.eastspring.com.tw/insights/global/rethinking-the-macro-landscape (檢索日期 May 11, 2024)
[18] Joyia, G. J., Liaqat, R. M., Farooq, A., & Rehman, S. (2017). Internet of Medical Things (IOMT): Applications, Benefits and Future Challenges in Healthcare Domain. Journal of Communications, 12(4), 240–247. https://doi.org/10.12720/jcm.12.4.240-247
[19] 陳慧玲. (2023). 企業風險管理與企業經營策略之探討：以G公司為例。未出版之碩士論文，國立政治大學／經營管理碩士學程(EMBA).臺北市 | zh_TW |
